136
ERC Advanced Life Support Doç.Dr.Oktay DEMİRKIRAN

Advanced Life Support194.27.141.99/dosya-depo/ders-notlari/oktay-demirkiran/Advanced_Li… · • Bizarre irregular waveform • No recognisable QRS complexes • Random frequency

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

  • ERC

    Advanced Life Support

    Doç.Dr.Oktay DEMİRKIRAN

  • ERC

    Chain of survival

  • ERC

    CARDIAC MONITORING &

    RHYTHM RECOGNITION

  • ERC

    Objectives

    To understand:• Indications & techniques for ECG

    monitoring• Basic electrocardiography• How to read a rhythm strip

    –cardiac arrest rhythms–peri-arrest arrhythmias

  • ERC

    Which patients?• Cardiac arrest or other important

    arrhythmias• Chest pain• Heart failure• Collapse / syncope• Shock / hypotension• Palpitations

  • ERC

    How to monitor the ECG (1):Monitoring leads

    • 3-lead system approximates to I, II, III

    • Colour coded• Remove hair• Apply over bone• Lead setting (II)• Gain

  • ERC

    How to monitor the ECG (2):Defibrillator paddles

    • Suitable for “quick-look”• Movement artefact• Risk of spurious

    asystole

  • ERC

    Cardiac arrest rhythms

    • Ventricular fibrillation• Pulseless ventricular tachycardia• Asystole• Pulseless Electrical Activity (PEA)

  • ERC

    How to monitor the ECG (3):Adhesive monitoring electrodes

    • “Hands-free”monitoring and defibrillation

  • ERC

    12-lead ECG

  • ERC

    12-lead ECG

    • 3D electrical activity from heart• More sophisticated ECG

    interpretation• ST segment analysis

  • ERC

    • Depolarisation initiated in SA node

    • Slow conduction through AV node

    • Rapid conduction through Purkinje fibres

    Basic electrocardiography (1)

  • ERC

    Basic electrocardiography (2)

    • P wave = atrialdepolarisation

    • QRS = ventricular depolarisation (< 0.12 s)

    • T wave = ventricular repolarisation

  • ERC

  • ERC

    Ventricular fibrillation• Bizarre irregular waveform• No recognisable QRS complexes• Random frequency and amplitude• Unco-ordinated electrical activity• Coarse / fine• Exclude artifact

    – movement– electrical interference

  • ERC

  • ERC

  • ERC

    Pulseless ventricular tachycardia

    • Monomorphic VT–Broad complex rhythm–Rapid rate–Constant QRS morphology

    • Polymorphic VT–Torsade de pointes

  • ERC

  • ERC

  • ERC

    Asystole

    • Absent ventricular (QRS) activity• Atrial activity (P waves) may persist• Rarely a straight line trace• Consider fine VF

  • ERC

  • ERC

  • ERC

    Pulseless Electrical Activity

    • Clinical features of cardiac arrest• ECG normally associated with an

    output

  • ERC

    How to read a rhythm strip1. Is there any electrical activity?2. What is the ventricular (QRS) rate?3. Is the QRS rhythm regular or irregular?4. Is the QRS width normal or prolonged?

    5. Is atrial activity present?6. How is it related to ventricular activity?

  • ERC

    ECG rhythm interpretation

    • Effective treatment often possible without precise ECG diagnosis

    • Haemodynamic consequences of any given rhythm will vary

    • Treat the patient not the rhythm

  • ERC

    What is the ventricular rate?• Normal 60-100 min-1

    • Bradycardia < 60 min-1

    • Tachycardia > 100 min-1

    Rate = 300Number of large squares between consecutive QRS complexes*

    * At standard paper speed of 25 mm sec-1, 5 large squares = 1 second

  • ERC

    Is the QRS rhythm regular or irregular?

    • Unclear at rapid heart rates• Compare R-R intervals• Irregularly irregular = AF

  • ERC

    DEFIBRILLATION

  • ERC

    Cardiac ArrestPrecordial Thump if appropriate

    BLS Algorithm if appropriate

    Attach Defib-Monitor

    AssessRhythm

    +/- Check PulseVF/VT Non-VF/VT

    Defibrillate X 3as necessary

    CPR 1 minCPR 3 min*

    * 1 min if immediatelyafter defibrillation

    During CPRCorrect reversible causes

    If not already:•check electrodes, paddle position and contact•attempt / verify: airway & O2,

    i.v. access•give epinephrine every 3 min•give amiodarone after 3 unsuccessful shocks

    Consider: buffers, magnesium, atropine

    Potential reversible causes:• Hypoxia• Hypovolaemia• Hypo/hyperkalaemia & metabolic disorders• Hypothermia• Tension pneumothorax• Tamponade• Toxic/therapeutic disorders• Thrombo-embolic & mechanical obstruction

    Universal ALSAlgorithm

  • ERC

    Unresponsive?

    Open airwayLook for signs of life

    Call resuscitation team

    CPR 30:2Until Defib-Monitor Attach

    AssessRhythm

    Shockable(VF/pulslessVT)

    Non shockable(PEA/ Asystole)

    1 Shock150-3600J biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2 for

    2 min

    Immediately resume:CPR 30:2 for

    2 min

    During CPRCorrect reversible causes

    •check electrodes, paddle position and contact•attempt / verify: airway & O2,

    i.v. accessGive interrupted compressions when airwaysecure•give epinephrine every 3-5 min

    Consider: amiodarone, magnesium, atropine

    Potential reversible causes:• Hypoxia• Hypovolaemia• Hypo/hyperkalaemia & metabolic disorders• Hypothermia• Tension pneumothorax• Tamponade• Toxic/therapeutic disorders• Thrombo-embolic & mechanical obstruction

    Universal ALSAlgorithm

  • ERC

    Mechanism of defibrillation• Definition

    “The termination of fibrillation or absence of VF/VT at 5 seconds after shock delivery”

    • Critical mass of myocardium depolarised• Natural pacemaker tissue resumes control

  • ERC

    DefibrillationSuccess depends on delivery of current to the myocardium

    Current flow depends upon:• Electrode position • Transthoracic impedance• Energy delivered• Body size

  • ERC

    Transthoracic Impedance

    Dependent upon:• Electrode size• Electrode/skin interface• Contact pressure• Phase of respiration• Sequential shocks

  • ERC

    Defibrillators• Design

    – Power source– Capacitor– Electrodes

    • Types– Manual– Automated– Monophasic or Biphasic waveform

  • ERC

    Defibrillator waveforms

    Damped Monophasic Truncated Biphasic

  • ERC

    Biphasic Defibrillators

    • Require less energy for defibrillation– smaller capacitors and batteries– lighter and more transportable

    • Repeated < 200 J biphasic shocks have higher success rate for terminating VF/VT than escalating monophasic shocks

  • ERC

    Goals for in-hospital defibrillation

    • “Healthcare providers with a duty to perform CPR should be trained, equipped, and authorised to perform defibrillation”

    • “The goal should be a collapse-to-shock interval of less than 3 minutes in all areas of the hospital”

  • ERC

  • ERC

  • ERC

  • ERC

    Automated external defibrillators• Analyse cardiac

    rhythm• Prepare for shock

    delivery• Specificity for

    recognition of shockable rhythm close to 100%

  • ERC

    Automated external defibrillators

    Advantages:• Less training required

    – no need for ECG interpretation • Suitable for “first-responder” defibrillation• Public access defibrillation (PAD)

    programs

  • ERC

    Automated External Defibrillation• Attach adhesive

    electrodes• Follow audible and visual

    instructions• Automated ECG analysis

    - stand clear • Charges automatically if

    shockable rhythm • +/- manual override

  • ERC

    Assess VictimAccording to BLS guidelines

    BLSIf AED not immediately available

    Switch defibrillator ONAttach electrodes

    Follow spoken/visual directions

    ANALYSEShock

    IndicatedNo shockIndicated

    After every 3 shocks

    CPR 1 minute

    If nocirculation

    CPR 1 minute

    AED Algorithm

  • ERC

  • ERC

    AED Use:• Airports• Bus terminals• Shopping malls• Hotels• Schools• Hospital wards• Aircrafts

  • ERC

  • ERC

  • ERC

    Manual Defibrillation

    Relies upon:• Operator recognition of

    ECG rhythm• Operator charging machine

    and delivering shock• Can be used for

    synchronised cardioversion

  • ERC

    Defibrillator Safety

    • Never hold both paddles in one hand• Charge only with paddles on casualty’s

    chest• Avoid direct or indirect contact • Wipe any water from the patient’s chest• Remove high-flow oxygen from zone of

    defibrillation

  • ERC

    Shock Energy• Initial shock energy 200 J*, repeat

    once if unsuccessful • Subsequent shocks at 360 J*• Shocks delivered in groups of three• If defibrillation restores the patient’s

    circulation and VF/VT recurs, start again at 200J*

    *or biphasic equivalent

  • ERC

    Defibrillation

    A series of 3 shocks should be delivered rapidly, do not interrupt the sequence for CPR or a pulse check unless:

    • Possible restoration of cardiac output• Uncertain ECG rhythm

  • ERC

    Manual Defibrillation (1)• Diagnose VF/VT from

    ECG and signs of cardiac arrest

    • Select correct energy level• Charge paddles on patient• Shout “stand clear”• Visual check of area• Check monitor• Deliver shock

  • ERC

    Manual Defibrillation (2)• Reassess rhythm• Keep paddles on chest between shocks• Increase energy level

    – use assistant, or– replace paddle/s in defibrillator and select

    energy level yourself• No BLS between shocks unless prolonged

    delays

  • ERC

    Synchronised cardioversion• Convert atrial or ventricular tachyarrhythmias• Shock synchronised to occur with the R wave• Short delay after pressing discharge buttons -

    keep defibrillator electrodes in place• Conscious patients: sedation or anaesthesia• Check mode if further shock/s required

  • ERC

    Pulseless VT is treated with an unsynchronised shock using

    the VF protocol

  • ERC

    Stres points

    • Wet chest• Hairy chest• Plasters• “Pacemaker”

  • ERC

  • ERC

    Summary• Defibrillation is the only effective means

    of restoring cardiac output for the patient in VF or pulseless VT

    • Defibrillation must be performed promptly, efficiently and safely

    • New technology has improved machine performance and simplified use

  • ERC

    ALS UNIVERSAL TREATMENT ALGORITHM

  • ERC

    Objectives

    To understand:• Treatment of patients in:

    –ventricular fibrillation and pulseless ventricular tachycardia

    –asystole or pulseless electrical activity (non-VF/VT rhythms)

  • ERC

    Unresponsive?

    Open airwayLook for signs of life

    Call resuscitation team

    CPR 30:2Until Defib-Monitor Attach

    AssessRhythm

    Shockable(VF/pulslessVT)

    Non shockable(PEA/ Asystole)

    1 Shock150-200J biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2 for

    2 min

    Immediately resume:CPR 30:2 for

    2 min

    During CPRCorrect reversible causes

    •check electrodes, paddle position and contact•attempt / verify: airway & O2,

    i.v. accessGive interrupted compressions when airwaysecure•give epinephrine every 3-5 min

    Consider: amiodarone, magnesium, atropine

    Potential reversible causes:• Hypoxia• Hypovolaemia• Hypo/hyperkalaemia & metabolic disorders• Hypothermia• Tension pneumothorax• Tamponade• Toxic/therapeutic disorders• Thrombo-embolic & mechanical obstruction

    Universal ALSAlgorithm

  • ERC

    • Attempt defibrillation. Give one shock of 150-200 J biphasic (360 J monophasic).• Immediately resume chest compressions (30:2) without reassessing the rhythm or feeling for

    a pulse• Continue CPR for 2 min, then pause briefly to check the monitor:

    – If VF/VT persists • Give a further (2nd) shock of 150-360 J biphasic (360 J monophasic). • Resume CPR immediately and continue for 2 min. • Pause briefly to check the monitor. • If VF/VT persists give adrenaline 1 mg IV followed immediately by a (3rd) shock of

    150-360 J biphasic (360 J monophasic). • Resume CPR immediately and continue for 2 min. • Pause briefly to check the monitor. • If VF/VT persists give amiodarone 300 mg IV followed immediately by a (4th)

    shock of 150-360 J biphasic (360 J monophasic). • Resume CPR immediately and continue for 2 min. • Give adrenaline 1 mg IV immediately before alternate shocks (i.e. approximately

    every 3-5 min).• Give further shocks after each 2 min period of CPR and after confirming that

    VF/VT persists.

  • ERC

    – If organised electrical activity compatible with a cardiac output is seen, check for a pulse• If a pulse is present, start post-

    resuscitation care• If no pulse is present, continue CPR and

    switch to the non-shockable algorithm– If asystole is seen, continue CPR and

    switch to the non-shockable algorithm.

  • ERC

    Cardiac ArrestPrecordial Thump if appropriate

    BLS Algorithm if appropriate

    Attach Defib-Monitor

    AssessRhythm

    +/- Check Pulse

    VF/VT Non-VF/VT

  • ERC

    Precordial thump

    • Mechanical shock

    • Indication:–witnessed or

    monitored cardiac arrest

  • ERC

    Precordial thump

    • Lower half of the sternum• From a height of about 20 cm• In first 10 seconds

  • ERC

    In-hospital Basic Life Support Patient Collapsed

    Shout for HELP and assess responsiveness

    Not responsive Responsive

    Call cardiac arrest team / Get defibrillatorStart BLS if defibrillator not immediately

    available

    Call for medical assistance

    Definite Pulse and Breathing Present?

    Apply pads / monitorDefibrillate if appropriate

    Ventilate with oxygenChest compressions

    ALS on arrival of Cardiac Arrest Team

    Airway manoeuvresOxygen, monitor, i.v.

    Find notesPrepare handover

    YesNo

  • ERC

    Cardiac ArrestPrecordial Thump if appropriate

    BLS Algorithm if appropriate

    Attach Defib-Monitor

    AssessRhythm

    +/- Check Pulse

    VF/VT Non-VF/VT

  • ERC

  • ERC

    Ventricular Fibrillation• Bizarre irregular waveform• No recognisable QRS complexes• Random frequency and amplitude• Unco-ordinated electrical activity• Coarse / fine• Exclude artifact

    – movement– electrical interference

  • ERC

  • ERC

    Pulseless Ventricular Tachycardia

    • Monomorphic VT–Broad complex rhythm–Rapid rate–Constant QRS morphology

    • Polymorphic VT–Torsade de pointes

  • ERC

    AssessRhythm

    VF/VT

    Defibrillate X 3as necessary

    CPR 1 min

    Ventricular Fibrillation/Pulseless Ventricular Tachycardia

  • ERC

    Assess the rhytm

    Shockable(VF / pulseless VT)

    Shockable150-200 J Biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2

    2 min(without reassesing the rhytm or feeling a pulse)

  • ERC

    Check the monitor

    VF / pulseless VT persist

    2nd shock150-200 J Biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2

    2 min

    VF / pulseless VT persist

    Adrenaline 1 mg (IV)

    3rd shock150-200 J Biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2

    2 min

    Check the monitor

    VF / pulseless VT persist

    Amiodarone 300 mg (IV)

    4th shock150-200 J Biphasic or

    360 J monophasic

    Immediately resume:CPR 30:2

    2 min

    Adrenaline 1 mg (İV)Every 3-5 min

    Immediately resume:CPR 30:2

    2 min

  • ERC

    • Drug-shock-CPR-rhytm check

  • ERC

    During CPRCorrect reversible causes

    If not already:• check electrodes, paddle position and contact• attempt / verify: airway & O2

    i.v. access• give epinephrine / adrenaline every 3 min• give amiodarone after 3 unsuccessful shocks

    Consider: buffers, magnesium, atropine

  • ERC

    Potential reversible causes:• Hypoxia• Hypovolaemia• Hypo/hyperkalaemia & metabolic disorders• Hypothermia• Tension pneumothorax• Tamponade• Toxic/therapeutic disorders• Thrombo-embolic & mechanical obstruction

  • ERC

    Chest compressions, airway and ventilation

    • Secure airway:–Tracheal tube–Laryngeal mask airway (LMA)–Combitube

    • Once airway secured, if possible, do not interrupt chest compressions for ventilation

  • ERC

    Intravenous access and drugs VF/VT

    • Central veins versus peripheral• Epinephrine / adrenaline 1 mg i.v. or

    2-3 mg tracheal tube• Consider amiodarone 300 mg if

    VF/VT persists after 3rd shock • Alternatively - lidocaine 100 mg• Consider magnesium 8 mmol (2g)

  • ERC

    Epinephrine/AdrenalineActions:α agonist arterial vasoconstriction ↑ systemic vascular resistance ↑ cerebral and coronary blood flow β agonist ↑ heart rate

    ↑ force of contraction↑ myocardial O2 demand(may increase ischaemia)

  • ERC

    Amiodarone

    Actions:

    • Lengthens duration of action potential• Prolongs Q-T interval• Mild negative inotrope - may cause

    hypotension

  • ERC

    Magnesium

    Actions:• Hypomagnesaemia often co-exists

    with hypokalaemia• Depresses neurological and

    myocardial function• Acts as a physiological calcium

    blocker

  • ERC

    Sodium BicarbonateActions:

    • Alkalinising agent (increases pH)But may:– increase carbon dioxide load– inhibit release of oxygen to tissues– impair myocardial contractility– cause hypernatraemia

  • ERC

    Non-VF/VT

    CPR 3 min** 1 min if immediately

    after defibrillation

    AssessRhythm

    +/- Check Pulse

    AsystolePulseless Electrical Activity (PEA)

  • ERC

    Assess the rhytm

    CPR30:2

    Check the leads are attachedwithout stopping CPR

    Adrenaline 1 mg (İV)Every 3-5 min

    Atropine 3 mg (İV)

    CPR 2 min30:2

    (Until airway secured)

    VF/VT recurs

    Shockable rhytm algoritm

    Adrenaline 1 mg (İV)Every 3-5 min

  • ERC

  • ERC

    Asystole

    • Absent ventricular (QRS) activity• Atrial activity (P waves) may persist• Rarely a straight line trace• Consider fine VF

  • ERC

    Asystole

    • Confirm:– check leads (view via leads I and II)– check ‘gain’

    • Epinephrine / adrenaline 1 mg i.v. every 3 minutes

    • Atropine 3 mg i.v. (or 6 mg via tracheal tube)

  • ERC

    Atropine

    Actions:

    • Blocks effects of vagus nerve• Increases sinus node automaticity• Increases atrioventricular conduction

  • ERC

    ‘Spurious’ asystole

    • Only occurs after shock delivered and subsequent monitoring with paddles and gel pads

    • More likely with increasing number of shocks and high chest impedance

    • Displays apparent ‘asystole’• Confirm rhythm with monitoring leads

  • ERC

  • ERC

    Pulseless Electrical Activity

    • Clinical features of cardiac arrest• ECG normally associated with an

    output

  • ERC

    Pulseless Electrical Activity

    • Exclude / treat reversible causes• Epinephrine / adrenaline 1 mg every 3

    minutes• Atropine 3 mg if PEA with rate < 60 min-1

    (6mg via tracheal tube)

  • ERC

    Non-VF/VT immediately after defibrillation

    • Withhold epinephrine /adrenaline and atropine - check rhythm and pulse after 1 minute of CPR –delay in recovery of monitor display–electrical stunning - few seconds of

    true asystole after defibrillation–myocardial stunning - temporarily

    impaired contractility

  • ERC

    DRUG DELIVERY DURING CPR

  • ERC

    Objectives

    • Understand the reasons for venous access

    • Review the equipment used • Outline the routes used for

    venous access• Understand the associated

    complications

  • ERC

    Access to the circulation allows:

    • Drug administration

    • Fluid administration

    • Taking blood samples

    • Insertion of a pacing wire

  • ERC

    Peripheral venous access

    • Upper limb–Dorsum of the hand–Forearm, antecubital fossa

    • Neck–External jugular vein

  • ERC

    Complications of peripheral venous access

    Early• Failure to cannulate vein• Haematoma formation• Extravasation of drugs, fluid• Damage to surrounding

    structures• Air embolus• Shearing/fracture of cannula

    or needle

    Late• Thrombophlebitis• Cellulitis

  • ERC

    Central venous access

    • Internal jugular vein

    • Subclavian vein

  • ERC

  • ERC

    Complications of central venous cannulation

    • Arterial puncture• Haematoma• Haemothorax• Pneumothorax• Air embolism• Damage to surrounding structures• Arrhythmias

  • ERC

    Tracheal administration of drugs

    • Inability to cannulate a vein• Need for tracheal tube in situ• Adjustment of dose and volume• Dispersal into bronchial tree

  • ERC

    Tracheal administration of drugs

    Drugs that canbe given via the trachea:

    • Epinephrine• Lidocaine• Atropine• Naloxone

    Drugs that cannot be given via the trachea

    • Amiodarone• Sodium bicarbonate• Calcium

  • ERC

    Summary• If a peripheral cannula is in place and

    working, use it initially

    • Central veins are the route of choice if expertise is available, but beware of complications

    • The tracheal route can be used with appropriate adjustment of dose

  • ERC

    DRUGS

  • ERC

    Objectives

    • To understand the indications, doses and actions of drugs used in resuscitation

    • To understand the indications, doses and actions of some of the common drugs used to treat peri-arrest arrhythmias

  • ERC

    EpinephrineIndications:

    • All cardiac arrest rhythms• Bradycardia• Special circumstances:

    –anaphylaxis

  • ERC

    EpinephrineDose:• 1 mg intravenous 10 ml 1:10,000 (1 ml

    1:1,000) every 2-3 mins during resuscitation• 2-3 mg via tracheal tube• 2–10 mcg min-1 for atropine resistant

    bradycardia• 0.5ml 1:1,000 i.m., 3-5 ml 1:10,000 i.v.

    in anaphylaxis, depending on severity

  • ERC

    EpinephrineActions:α agonist arterial vasoconstriction ↑ systemic vascular resistance ↑ cerebral and coronary blood flow

    β agonist ↑ heart rate↑ force of contraction↑ myocardial O2 demand(may increase ischaemia)

  • ERC

    Atropine

    Indications:

    • Asystole• Symptomatic bradycardias• PEA (rate < 60 beats min-1)

  • ERC

    AtropineDose:• Asystole / PEA (rate < 60 beats min-1)

    – 3 mg i.v., once only– 6 mg via tracheal tube

    • Bradycardia– 0.5 mg i.v., repeated as necessary,

    maximum 3 mg

  • ERC

    AtropineActions:• Blocks effects of vagus nerve

    • Increases sinus node automaticity

    • Increases atrioventricular conduction

  • ERC

    Amiodarone

    Indications:

    • Refractory VF / Pulseless VT• Haemodynamically stable VT• Other resistant tachyarrhythmias

  • ERC

    AmiodaroneDose:

    • Refractory VF / Pulseless VT– 300 mg in 20 ml 5% dextrose, bolus i.v.

    • Stable tachyarrhythmias– 150 mg in 20 ml 5% dextrose over 10 mins– Repeat 150 mg if necessary– 300 mg in 100 ml 5% dextrose over 1 hour

  • ERC

    Amiodarone

    Actions:

    • Lengthens duration of action potential• Prolongs Q-T interval• Mild negative inotrope - may cause

    hypotension

  • ERC

    MagnesiumIndications:

    • Shock refractory VF (with possible hypomagnesaemia)

    • Ventricular tachyarrhythmias (with possible hypomagnesaemia)

    • Torsades de pointes

  • ERC

    MagnesiumDose:

    Shock Refractory VF• 2–4 ml 50% (4–8 mmol) i.v. over 1-2 mins• Can be repeated after 10-15 minutes

    Other circumstances• 5 ml of 50% (10 mmol) i.v. over 30 mins

  • ERC

    Magnesium

    Actions:

    • Depresses neurological and myocardial function

    • Acts as a physiological calcium blocker

  • ERC

    LidocaineIndications:

    • Refractory VF / Pulseless VT– when amiodarone is unavailable

    • Haemodynamically stable VT– as an alternative to amiodarone

  • ERC

    LidocaineDose:• Refractory VF / Pulseless VT

    – 100 mg i.v.– further boluses of 50 mg, max 200 mg

    • Haemodynamically stable VT– 50 mg i.v.– further boluses of 50 mg, max 200 mg

    • Reduce dose in elderly or hepatic failure

  • ERC

    Sodium Bicarbonate

    Indications:

    • Severe metabolic acidosis (pH < 7.1)• Hyperkalaemia• Special circumstance

    –Tricyclic antidepressant poisoning

  • ERC

    Sodium Bicarbonate

    Dose:

    • 50 mmol (50 ml of 8.4% solution) i.v.

  • ERC

    Sodium BicarbonateActions:• Alkalinizing agent (increases pH)

    But may:– increase carbon dioxide load– inhibit release of oxygen to tissues– impair myocardial contractility– cause hypernatraemia– interact with adrenaline

  • ERC

    Calcium

    Actions:• Essential for normal cardiac contraction• Excess may lead to arrhythmias• The trigger for cell death in the ischaemic myocardium •Excess may impair cerebral recovery

  • ERC

    CalciumIndications:• Pulseless electrical activity caused by:

    – severe hyperkalaemia– severe hypocalcaemia– overdose of calcium channel blocking

    drugsDose• 10 ml 10% calcium chloride (6.8 mmol)

    Do not give immediately before or after sodium bicarbonate

  • ERC

    Adenosine

    Indications:

    • Broad complex tachycardia, uncertain aetiology

    • Paroxysmal supraventricular tachycardia

  • ERC

    AdenosineDose:

    • 6 mg intravenously, by rapid injection

    If necessary, three further doses each of 12 mg can be given every 1–2 mins

  • ERC

    Adenosine

    Actions:• Slows conduction across the AV node

    Must only be used in a monitored environment

  • ERC

    NaloxoneDose:

    • 0.2 - 2.0 mg i.v.• May need to be repeated up to a

    maximum of 10 mg• May need an infusion

  • ERC

    Naloxone

    Indications:

    • Opioid overdose• Respiratory depression secondary to

    opioid administration

  • ERC

    NaloxoneActions:

    • Opioid receptor antagonist• Reverses all opioid effects, particularly

    respiratory and cerebral• May cause severe agitation in opioid dependence

  • ERC

    Summary

    • Indications, dose and actions of drugs used during cardiac arrest

    • Indications, dose and actions of drugs used in the management of peri-arrest arrhythmias

    Advanced Life SupportChain of survivalCARDIAC MONITORING �& �RHYTHM RECOGNITIONObjectivesWhich patients?How to monitor the ECG (1):�Monitoring leadsHow to monitor the ECG (2):�Defibrillator paddlesCardiac arrest rhythmsHow to monitor the ECG (3):�Adhesive monitoring electrodes12-lead ECG12-lead ECGBasic electrocardiography (1)Basic electrocardiography (2)Ventricular fibrillationPulseless ventricular tachycardiaAsystolePulseless Electrical ActivityHow to read a rhythm stripECG rhythm interpretationWhat is the ventricular rate?Is the QRS rhythm regular or irregular?DEFIBRILLATIONMechanism of defibrillationDefibrillationTransthoracic ImpedanceDefibrillatorsDefibrillator waveformsBiphasic DefibrillatorsGoals for in-hospital defibrillationAutomated external defibrillatorsAutomated external defibrillatorsAutomated External DefibrillationAED Use:Manual DefibrillationDefibrillator SafetyShock EnergyDefibrillationManual Defibrillation (1)Manual Defibrillation (2)Synchronised cardioversionStres pointsSummaryALS UNIVERSAL �TREATMENT ALGORITHM�ObjectivesPrecordial thumpPrecordial thumpVentricular FibrillationPulseless Ventricular TachycardiaChest compressions, airway and ventilationIntravenous access and drugs �VF/VTEpinephrine/AdrenalineAmiodaroneMagnesiumSodium BicarbonateAsystoleAsystoleAtropine‘Spurious’ asystolePulseless Electrical ActivityPulseless Electrical ActivityNon-VF/VT immediately after defibrillationDRUG DELIVERY DURING CPRObjectivesPeripheral venous accessComplications of peripheral �venous accessCentral venous accessComplications of central venous cannulationTracheal administration �of drugsTracheal administration of drugsSummary�DRUGSObjectivesEpinephrineEpinephrineEpinephrineAtropineAtropineAtropineAmiodaroneAmiodaroneAmiodaroneMagnesiumMagnesiumMagnesiumLidocaineLidocaineSodium BicarbonateSodium BicarbonateSodium BicarbonateCalciumCalciumAdenosineAdenosineAdenosineNaloxoneNaloxoneNaloxoneSummary